Report Detail

Request for Sample of this report

Other Global Antibody Conjugation Service Market 2026 by Company, Regions, Type and Application, Forecast to 2032

  • RnM4679785
    • |
  • 26 February, 2026
    • |
  • Global
    • |
  • 153 Pages
    • |
  • GIR
    • |
  • Other

According to our (Global Info Research) latest study, the global Antibody Conjugation Service market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
Antibody conjugation service refers to a process in which antibodies are chemically modified by attaching various tags or ligands to their specific binding sites, enabling them to bind to various targets such as cells, proteins, or other molecules. This process is typically performed by specialized laboratories or service providers using various conjugation techniques such as click conjugation, biotin-avidin binding, etc. The goal of this service is to improve the specificity and affinity of antibodies for their targets, as well as to enhance their functional capabilities.
The industry trend for antibody conjugation service is towards increasing use in pharmaceutical and biotechnology research and development, as well as in clinical settings. With the growing demand for more advanced and specific antibody-based diagnostic and therapeutic tools, antibody conjugation services are becoming increasingly important. Additionally, the increasing use of antibody-based drugs in oncology and other diseases is driving the demand for such services, as they enable the development of more effective and targeted treatment strategies. Furthermore, the trend towards more sustainable and environmentally friendly research and production methods is also contributing to the growth of antibody conjugation services, as they reduce the use of toxic chemicals and minimize the environmental impact of antibody production.
This report is a detailed and comprehensive analysis for global Antibody Conjugation Service market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Antibody Conjugation Service market size and forecasts, in consumption value ($ Million), 2021-2032
Global Antibody Conjugation Service market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Antibody Conjugation Service market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Antibody Conjugation Service market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Antibody Conjugation Service
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Antibody Conjugation Service market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include ProSci, Inc, Thermo Fisher Scientific, Abcam, Cell Signaling Technology, Bio X Cell, SouthernBiotech, Novus Biologicals, GenScript, Leinco Technologies, Standard BioTools, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Antibody Conjugation Service market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chemical Compound
Fluorescent Group
Isotope
Protein
Market segment by Application
Biotechnology
Medical
University
Others
Market segment by players, this report covers
ProSci, Inc
Thermo Fisher Scientific
Abcam
Cell Signaling Technology
Bio X Cell
SouthernBiotech
Novus Biologicals
GenScript
Leinco Technologies
Standard BioTools
AlphaThera
Creative Biolabs
Antibodies
Boster Biological Technology
Cygnus Technologies
Cayman Chemical
GeneTex
ProteoGenix
Levena Biopharma
Merck
Lonza
Charles River
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Antibody Conjugation Service product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Antibody Conjugation Service, with revenue, gross margin, and global market share of Antibody Conjugation Service from 2021 to 2026.
Chapter 3, the Antibody Conjugation Service competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Antibody Conjugation Service market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Antibody Conjugation Service.
Chapter 13, to describe Antibody Conjugation Service research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Antibody Conjugation Service by Type
    • 1.3.1 Overview: Global Antibody Conjugation Service Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Antibody Conjugation Service Consumption Value Market Share by Type in 2025
    • 1.3.3 Chemical Compound
    • 1.3.4 Fluorescent Group
    • 1.3.5 Isotope
    • 1.3.6 Protein
  • 1.4 Global Antibody Conjugation Service Market by Application
    • 1.4.1 Overview: Global Antibody Conjugation Service Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Biotechnology
    • 1.4.3 Medical
    • 1.4.4 University
    • 1.4.5 Others
  • 1.5 Global Antibody Conjugation Service Market Size & Forecast
  • 1.6 Global Antibody Conjugation Service Market Size and Forecast by Region
    • 1.6.1 Global Antibody Conjugation Service Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Antibody Conjugation Service Market Size by Region, (2021-2032)
    • 1.6.3 North America Antibody Conjugation Service Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Antibody Conjugation Service Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Antibody Conjugation Service Market Size and Prospect (2021-2032)
    • 1.6.6 South America Antibody Conjugation Service Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Antibody Conjugation Service Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 ProSci, Inc
    • 2.1.1 ProSci, Inc Details
    • 2.1.2 ProSci, Inc Major Business
    • 2.1.3 ProSci, Inc Antibody Conjugation Service Product and Solutions
    • 2.1.4 ProSci, Inc Antibody Conjugation Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 ProSci, Inc Recent Developments and Future Plans
  • 2.2 Thermo Fisher Scientific
    • 2.2.1 Thermo Fisher Scientific Details
    • 2.2.2 Thermo Fisher Scientific Major Business
    • 2.2.3 Thermo Fisher Scientific Antibody Conjugation Service Product and Solutions
    • 2.2.4 Thermo Fisher Scientific Antibody Conjugation Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Thermo Fisher Scientific Recent Developments and Future Plans
  • 2.3 Abcam
    • 2.3.1 Abcam Details
    • 2.3.2 Abcam Major Business
    • 2.3.3 Abcam Antibody Conjugation Service Product and Solutions
    • 2.3.4 Abcam Antibody Conjugation Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Abcam Recent Developments and Future Plans
  • 2.4 Cell Signaling Technology
    • 2.4.1 Cell Signaling Technology Details
    • 2.4.2 Cell Signaling Technology Major Business
    • 2.4.3 Cell Signaling Technology Antibody Conjugation Service Product and Solutions
    • 2.4.4 Cell Signaling Technology Antibody Conjugation Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Cell Signaling Technology Recent Developments and Future Plans
  • 2.5 Bio X Cell
    • 2.5.1 Bio X Cell Details
    • 2.5.2 Bio X Cell Major Business
    • 2.5.3 Bio X Cell Antibody Conjugation Service Product and Solutions
    • 2.5.4 Bio X Cell Antibody Conjugation Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Bio X Cell Recent Developments and Future Plans
  • 2.6 SouthernBiotech
    • 2.6.1 SouthernBiotech Details
    • 2.6.2 SouthernBiotech Major Business
    • 2.6.3 SouthernBiotech Antibody Conjugation Service Product and Solutions
    • 2.6.4 SouthernBiotech Antibody Conjugation Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 SouthernBiotech Recent Developments and Future Plans
  • 2.7 Novus Biologicals
    • 2.7.1 Novus Biologicals Details
    • 2.7.2 Novus Biologicals Major Business
    • 2.7.3 Novus Biologicals Antibody Conjugation Service Product and Solutions
    • 2.7.4 Novus Biologicals Antibody Conjugation Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Novus Biologicals Recent Developments and Future Plans
  • 2.8 GenScript
    • 2.8.1 GenScript Details
    • 2.8.2 GenScript Major Business
    • 2.8.3 GenScript Antibody Conjugation Service Product and Solutions
    • 2.8.4 GenScript Antibody Conjugation Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 GenScript Recent Developments and Future Plans
  • 2.9 Leinco Technologies
    • 2.9.1 Leinco Technologies Details
    • 2.9.2 Leinco Technologies Major Business
    • 2.9.3 Leinco Technologies Antibody Conjugation Service Product and Solutions
    • 2.9.4 Leinco Technologies Antibody Conjugation Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Leinco Technologies Recent Developments and Future Plans
  • 2.10 Standard BioTools
    • 2.10.1 Standard BioTools Details
    • 2.10.2 Standard BioTools Major Business
    • 2.10.3 Standard BioTools Antibody Conjugation Service Product and Solutions
    • 2.10.4 Standard BioTools Antibody Conjugation Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Standard BioTools Recent Developments and Future Plans
  • 2.11 AlphaThera
    • 2.11.1 AlphaThera Details
    • 2.11.2 AlphaThera Major Business
    • 2.11.3 AlphaThera Antibody Conjugation Service Product and Solutions
    • 2.11.4 AlphaThera Antibody Conjugation Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 AlphaThera Recent Developments and Future Plans
  • 2.12 Creative Biolabs
    • 2.12.1 Creative Biolabs Details
    • 2.12.2 Creative Biolabs Major Business
    • 2.12.3 Creative Biolabs Antibody Conjugation Service Product and Solutions
    • 2.12.4 Creative Biolabs Antibody Conjugation Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Creative Biolabs Recent Developments and Future Plans
  • 2.13 Antibodies
    • 2.13.1 Antibodies Details
    • 2.13.2 Antibodies Major Business
    • 2.13.3 Antibodies Antibody Conjugation Service Product and Solutions
    • 2.13.4 Antibodies Antibody Conjugation Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Antibodies Recent Developments and Future Plans
  • 2.14 Boster Biological Technology
    • 2.14.1 Boster Biological Technology Details
    • 2.14.2 Boster Biological Technology Major Business
    • 2.14.3 Boster Biological Technology Antibody Conjugation Service Product and Solutions
    • 2.14.4 Boster Biological Technology Antibody Conjugation Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Boster Biological Technology Recent Developments and Future Plans
  • 2.15 Cygnus Technologies
    • 2.15.1 Cygnus Technologies Details
    • 2.15.2 Cygnus Technologies Major Business
    • 2.15.3 Cygnus Technologies Antibody Conjugation Service Product and Solutions
    • 2.15.4 Cygnus Technologies Antibody Conjugation Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Cygnus Technologies Recent Developments and Future Plans
  • 2.16 Cayman Chemical
    • 2.16.1 Cayman Chemical Details
    • 2.16.2 Cayman Chemical Major Business
    • 2.16.3 Cayman Chemical Antibody Conjugation Service Product and Solutions
    • 2.16.4 Cayman Chemical Antibody Conjugation Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 Cayman Chemical Recent Developments and Future Plans
  • 2.17 GeneTex
    • 2.17.1 GeneTex Details
    • 2.17.2 GeneTex Major Business
    • 2.17.3 GeneTex Antibody Conjugation Service Product and Solutions
    • 2.17.4 GeneTex Antibody Conjugation Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.17.5 GeneTex Recent Developments and Future Plans
  • 2.18 ProteoGenix
    • 2.18.1 ProteoGenix Details
    • 2.18.2 ProteoGenix Major Business
    • 2.18.3 ProteoGenix Antibody Conjugation Service Product and Solutions
    • 2.18.4 ProteoGenix Antibody Conjugation Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.18.5 ProteoGenix Recent Developments and Future Plans
  • 2.19 Levena Biopharma
    • 2.19.1 Levena Biopharma Details
    • 2.19.2 Levena Biopharma Major Business
    • 2.19.3 Levena Biopharma Antibody Conjugation Service Product and Solutions
    • 2.19.4 Levena Biopharma Antibody Conjugation Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.19.5 Levena Biopharma Recent Developments and Future Plans
  • 2.20 Merck
    • 2.20.1 Merck Details
    • 2.20.2 Merck Major Business
    • 2.20.3 Merck Antibody Conjugation Service Product and Solutions
    • 2.20.4 Merck Antibody Conjugation Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.20.5 Merck Recent Developments and Future Plans
  • 2.21 Lonza
    • 2.21.1 Lonza Details
    • 2.21.2 Lonza Major Business
    • 2.21.3 Lonza Antibody Conjugation Service Product and Solutions
    • 2.21.4 Lonza Antibody Conjugation Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.21.5 Lonza Recent Developments and Future Plans
  • 2.22 Charles River
    • 2.22.1 Charles River Details
    • 2.22.2 Charles River Major Business
    • 2.22.3 Charles River Antibody Conjugation Service Product and Solutions
    • 2.22.4 Charles River Antibody Conjugation Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.22.5 Charles River Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Antibody Conjugation Service Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Antibody Conjugation Service by Company Revenue
    • 3.2.2 Top 3 Antibody Conjugation Service Players Market Share in 2025
    • 3.2.3 Top 6 Antibody Conjugation Service Players Market Share in 2025
  • 3.3 Antibody Conjugation Service Market: Overall Company Footprint Analysis
    • 3.3.1 Antibody Conjugation Service Market: Region Footprint
    • 3.3.2 Antibody Conjugation Service Market: Company Product Type Footprint
    • 3.3.3 Antibody Conjugation Service Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Antibody Conjugation Service Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Antibody Conjugation Service Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Antibody Conjugation Service Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Antibody Conjugation Service Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Antibody Conjugation Service Consumption Value by Type (2021-2032)
  • 6.2 North America Antibody Conjugation Service Market Size by Application (2021-2032)
  • 6.3 North America Antibody Conjugation Service Market Size by Country
    • 6.3.1 North America Antibody Conjugation Service Consumption Value by Country (2021-2032)
    • 6.3.2 United States Antibody Conjugation Service Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Antibody Conjugation Service Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Antibody Conjugation Service Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Antibody Conjugation Service Consumption Value by Type (2021-2032)
  • 7.2 Europe Antibody Conjugation Service Consumption Value by Application (2021-2032)
  • 7.3 Europe Antibody Conjugation Service Market Size by Country
    • 7.3.1 Europe Antibody Conjugation Service Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Antibody Conjugation Service Market Size and Forecast (2021-2032)
    • 7.3.3 France Antibody Conjugation Service Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Antibody Conjugation Service Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Antibody Conjugation Service Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Antibody Conjugation Service Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Antibody Conjugation Service Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Antibody Conjugation Service Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Antibody Conjugation Service Market Size by Region
    • 8.3.1 Asia-Pacific Antibody Conjugation Service Consumption Value by Region (2021-2032)
    • 8.3.2 China Antibody Conjugation Service Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Antibody Conjugation Service Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Antibody Conjugation Service Market Size and Forecast (2021-2032)
    • 8.3.5 India Antibody Conjugation Service Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Antibody Conjugation Service Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Antibody Conjugation Service Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Antibody Conjugation Service Consumption Value by Type (2021-2032)
  • 9.2 South America Antibody Conjugation Service Consumption Value by Application (2021-2032)
  • 9.3 South America Antibody Conjugation Service Market Size by Country
    • 9.3.1 South America Antibody Conjugation Service Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Antibody Conjugation Service Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Antibody Conjugation Service Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Antibody Conjugation Service Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Antibody Conjugation Service Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Antibody Conjugation Service Market Size by Country
    • 10.3.1 Middle East & Africa Antibody Conjugation Service Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Antibody Conjugation Service Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Antibody Conjugation Service Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Antibody Conjugation Service Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Antibody Conjugation Service Market Drivers
  • 11.2 Antibody Conjugation Service Market Restraints
  • 11.3 Antibody Conjugation Service Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Antibody Conjugation Service Industry Chain
  • 12.2 Antibody Conjugation Service Upstream Analysis
  • 12.3 Antibody Conjugation Service Midstream Analysis
  • 12.4 Antibody Conjugation Service Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Antibody Conjugation Service. Industry analysis & Market Report on Antibody Conjugation Service is a syndicated market report, published as Global Antibody Conjugation Service Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Antibody Conjugation Service market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo